Sponsor

Santen Pharmaceutical Co., Ltd.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Santen Pharmaceutical Co., Ltd. appears in 14 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials14
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

14 shown
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in ChinaNCT06666855 · lead sponsor · 2024-11-28
ACTIVE_NOT_RECRUITING
A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionNCT05495061 · lead sponsor · 2022-08-09
COMPLETED
A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular HypertensionNCT05503901 · lead sponsor · 2022-08-08
COMPLETED
A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular HypertensionNCT03822559 · lead sponsor · 2019-01-20
COMPLETED
A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHTNCT02981446 · lead sponsor · 2017-01-01
COMPLETED
A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI StudyNCT02822742 · lead sponsor · 2016-07-02
COMPLETED
A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE StudyNCT02822729 · lead sponsor · 2016-07-01
COMPLETED
A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-NCT02623738 · lead sponsor · 2015-12-06
COMPLETED
Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial AsthmaNCT02097537 · lead sponsor · 2014-02-01
COMPLETED
DE-111 Against Timolol Ophthalmic Solution 0.5%NCT01342094 · lead sponsor · 2011-05-01
COMPLETED
DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionNCT01343082 · lead sponsor · 2011-05-01
COMPLETED
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%NCT01342081 · lead sponsor · 2011-05-01
COMPLETED
To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular HypertensionNCT00656240 · lead sponsor
COMPLETED
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular HypertensionNCT00657579 · lead sponsor
COMPLETED

Sponsor roles

lead sponsor14
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.